Czuczman MS - Search Results

1

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.

Czuczman MS, Kahanic S, Forero A, Davis G, Munteanu M, Van Den Neste E, Offner F, Bron D, Quick D, Fowler N. Czuczman MS, et al. Ann Hematol. 2015 Apr;94(4):633-41. doi: 10.1007/s00277-014-2269-8. Epub 2015 Jan 30. Ann Hematol. 2015. PMID: 25630297 Clinical Trial.

2

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.

Czuczman MS, Grillo-López AJ, White CA, Saleh M, Gordon L, LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C. Czuczman MS, et al. J Clin Oncol. 1999 Jan;17(1):268-76. doi: 10.1200/JCO.1999.17.1.268. J Clin Oncol. 1999. PMID: 10458242 Clinical Trial.

3

CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma.

Czuczman MS. Czuczman MS. Semin Oncol. 1999 Oct;26(5 Suppl 14):88-96. Semin Oncol. 1999. PMID: 10561023 Clinical Trial.

4

A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma.

Khorana A, Bunn P, McLaughlin P, Vose J, Stewart C, Czuczman MS. Khorana A, et al. Among authors: czuczman ms. Leuk Lymphoma. 2001 Mar;41(1-2):77-87. doi: 10.3109/10428190109057956. Leuk Lymphoma. 2001. PMID: 11342359 Clinical Trial.

5

Immunochemotherapy in indolent non-Hodgkin's lymphoma.

Czuczman MS. Czuczman MS. Semin Oncol. 2002 Apr;29(2 Suppl 6):11-7. doi: 10.1053/sonc.2002.32748. Semin Oncol. 2002. PMID: 12040529 Review.

6

Radioimmunotherapy in non-Hodgkin lymphoma.

Chanan-Khan A, Czuczman MS. Chanan-Khan A, et al. Among authors: czuczman ms. Curr Opin Oncol. 2002 Sep;14(5):484-9. doi: 10.1097/00001622-200209000-00003. Curr Opin Oncol. 2002. PMID: 12192266 Review.

7

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients.

Benekli M, Hahn T, Shafi F, Qureshi A, Alam AR, Czuczman MS, Bernstein ZP, Chanan-Khan AA, Becker JL, McCarthy PL. Benekli M, et al. Among authors: czuczman ms. Bone Marrow Transplant. 2003 Jul;32(2):139-43. doi: 10.1038/sj.bmt.1704106. Bone Marrow Transplant. 2003. PMID: 12838277

8

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.

Hahn T, Wolff SN, Czuczman M, Fisher RI, Lazarus HM, McCarthy PL, Vose J, Warren L, Watt R; American Society for Blood and Marrow Transplantation (ASBMT). Hahn T, et al. Biol Blood Marrow Transplant. 2003 Oct;9(10):667. doi: 10.1016/j.bbmt.2003.09.012. Biol Blood Marrow Transplant. 2003. PMID: 14569563 No abstract available.

9

Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.

Chanan-Khan A, Islam T, Alam A, Miller KC, Gibbs J, Barcos M, Czuczman MS, Paplham P, Hahn T, McCarthy P. Chanan-Khan A, et al. Among authors: czuczman ms. Leuk Lymphoma. 2004 Aug;45(8):1673-5. doi: 10.1080/10428190310001609924. Leuk Lymphoma. 2004. PMID: 15370223

10

Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.

Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-López AJ. Czuczman MS, et al. J Clin Oncol. 2004 Dec 1;22(23):4711-6. doi: 10.1200/JCO.2004.04.020. Epub 2004 Oct 13. J Clin Oncol. 2004. PMID: 15483015 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters